Clinical Trials Directory

Trials / Completed

CompletedNCT01340534

Supplemental Perioperative Oxygen to Reduce the Incidence of Post-cesarean Wound Infection

Supplemental Perioperative Oxygen at 80% FIO2 to Reduce the Incidence of Post-cesarean Wound Infection. A Randomised, Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
370 (actual)
Sponsor
Saint Thomas Hospital, Panama · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the use of supplemental oxygen at 80% FIO2 can reduce the incidence of surgical site infection after emergency cesarean section.

Detailed description

Surgical site infection (SSI) is one of the most important complications that can develop after a cesarean section. SSI can be mild or it can develop into septic shock and death, being cesarean section the most important cause of puerperal infections. Supplemental oxygen at high doses has been advocated as a protective factor for SSI. The purpose of this study is to determine if the use of oxygen at high doses (80% FIO2)can reduce the incidence of SSI after emergency cesarean section.

Conditions

Interventions

TypeNameDescription
DEVICESupplemental oxygen 80% FIO2Use of oxygen 80% FIO2 during surgery and 2 hours after the procedure. For this purpose an oxygen mask with reservoir will be used (to guarantee the supply of 80% oxygen during and after surgery)
PROCEDUREUse of air (no oxygen during surgery)No use of oxygen during surgery or in the 2 hours after the procedure.

Timeline

Start date
2011-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-04-22
Last updated
2015-01-05

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT01340534. Inclusion in this directory is not an endorsement.